Intrathecal synthesis of tumor markers is a highly sensitive test in the diagnosis of leptomeningeal metastasis from solid cancers
-
Elena Corsini
Abstract
Background: Identification of neoplastic cells in cerebrospinal fluid (CSF) by cytological analysis is the key diagnostic feature of leptomeningeal metastasis (LM). Because of the lack of sensitivity of this test, considerable efforts have been made to identify alternative diagnostic markers. Data from the literature suggest that measurement of tumor markers (TM) in CSF may be helpful for improving the diagnosis.
Methods: We analyzed the concentrations of the TM carcinoembryonic antigen (CEA), CA15.3, CA125 and CA19.9 in both CSF and serum from 18 patients with neoplastic meningitis diagnosed by CSF cytology. We also performed these same measurements in 50 patients affected by other neurological diseases (OND) in order to evaluate putative intrathecal synthesis. In addition, CSF and serum concentrations of the proangiogenic factor VEGF (vascular endothelial growth factor) were evaluated.
Results: All LM patients showed intrathecal synthesis for at least one TM. In one patient, a negative CSF cytology after treatment paralleled normalization of tumor marker synthesis. None of the OND patients displayed intrathecal TM synthesis. The VEGF Index (CSF/serum VEGF relative to CSF/serum albumin ratios) was significantly higher in LM patients compared with the control group. However, significant overlap between LM patients and values seen in those with OND was observed.
Conclusions: Evaluation of intrathecal TM synthesis is a specific, sensitive, reliable, and reproducible diagnostic tool, and is useful to support diagnosis of carcinomatous meningitis.
Clin Chem Lab Med 2009;47:874–9.
©2009 by Walter de Gruyter Berlin New York
Artikel in diesem Heft
- Editorials
- Change through continuity
- EFCC and Labs are Vital announce an Award for Outcomes Research in Laboratory Medicine
- Review
- The prevalence and risk factors for gallstone disease
- Opinion Paper
- Measurement uncertainty of test kit results – the ELISA example
- Genetics and Molecular Diagnostics
- Expression of RhoA and RhoC in colorectal carcinoma and its relations with clinicopathological parameters
- High-sensitive microarray substrates specifically designed to improve sensitivity for the identification of fetal paternally inherited sequences in maternal plasma
- A new CYP21A2 nonsense mutation causing severe 21-hydroxylase deficiency
- The haptoglobin phenotype is associated with the Epstein-Barr virus antibody titer
- General Clinical Chemistry and Laboratory Medicine
- Evaluation of analytical performance of the Pathfast® cardiac troponin I
- Diagnostic performance of the ARCHITECT C-Peptide immunoassay
- Clinical significance of anti-cyclic citrullinated peptide antibodies in Egyptian patients with chronic hepatitis C virus genotype IV infection
- Cerebrospinal fluid and serum uric acid levels in patients with multiple sclerosis
- Therapeutic drug monitoring and drugs of abuse testing on the cobas® 6000 analyzer series: analytical performance under routine-like conditions
- Is serum γ-glutamyltransferase an exposure marker of xenobiotics? Empirical evidence with polycylic aromatic hydrocarbon
- Reference Values and Biological Variations
- Gender difference and determinants of C-reactive protein level in Korean adults
- Cancer Diagnostics
- Quantitative telomerase activity in circulating human leukocytes: utility of real-time telomeric repeats amplification protocol (RQ-TRAP) in a clinical/epidemiological setting
- Intrathecal synthesis of tumor markers is a highly sensitive test in the diagnosis of leptomeningeal metastasis from solid cancers
- Letters to the Editor
- Hyperleukocytosis: pseudohyperkalaemia and other biochemical abnormalities in hyperleukocytosis
- Review of the prevalence of macroprolactinaemia in a South African hospital
- A novel aberrant form of e13a2 BCR-ABL1 transcript in chronic myelogenous leukemia undetectable with the standardized real-time quantitative polymerase chain reaction from the Europe Against Cancer Program
- Positive correlations between serum and plasma matrix metalloproteinase (MMP)-2 or MMP-9 levels in disease conditions
- Doubt on prevention of false-positive results of cardiac troponin I by recentrifugation
- Plasmalogens as a marker of elevated systemic oxidative stress in Parkinson's disease
Artikel in diesem Heft
- Editorials
- Change through continuity
- EFCC and Labs are Vital announce an Award for Outcomes Research in Laboratory Medicine
- Review
- The prevalence and risk factors for gallstone disease
- Opinion Paper
- Measurement uncertainty of test kit results – the ELISA example
- Genetics and Molecular Diagnostics
- Expression of RhoA and RhoC in colorectal carcinoma and its relations with clinicopathological parameters
- High-sensitive microarray substrates specifically designed to improve sensitivity for the identification of fetal paternally inherited sequences in maternal plasma
- A new CYP21A2 nonsense mutation causing severe 21-hydroxylase deficiency
- The haptoglobin phenotype is associated with the Epstein-Barr virus antibody titer
- General Clinical Chemistry and Laboratory Medicine
- Evaluation of analytical performance of the Pathfast® cardiac troponin I
- Diagnostic performance of the ARCHITECT C-Peptide immunoassay
- Clinical significance of anti-cyclic citrullinated peptide antibodies in Egyptian patients with chronic hepatitis C virus genotype IV infection
- Cerebrospinal fluid and serum uric acid levels in patients with multiple sclerosis
- Therapeutic drug monitoring and drugs of abuse testing on the cobas® 6000 analyzer series: analytical performance under routine-like conditions
- Is serum γ-glutamyltransferase an exposure marker of xenobiotics? Empirical evidence with polycylic aromatic hydrocarbon
- Reference Values and Biological Variations
- Gender difference and determinants of C-reactive protein level in Korean adults
- Cancer Diagnostics
- Quantitative telomerase activity in circulating human leukocytes: utility of real-time telomeric repeats amplification protocol (RQ-TRAP) in a clinical/epidemiological setting
- Intrathecal synthesis of tumor markers is a highly sensitive test in the diagnosis of leptomeningeal metastasis from solid cancers
- Letters to the Editor
- Hyperleukocytosis: pseudohyperkalaemia and other biochemical abnormalities in hyperleukocytosis
- Review of the prevalence of macroprolactinaemia in a South African hospital
- A novel aberrant form of e13a2 BCR-ABL1 transcript in chronic myelogenous leukemia undetectable with the standardized real-time quantitative polymerase chain reaction from the Europe Against Cancer Program
- Positive correlations between serum and plasma matrix metalloproteinase (MMP)-2 or MMP-9 levels in disease conditions
- Doubt on prevention of false-positive results of cardiac troponin I by recentrifugation
- Plasmalogens as a marker of elevated systemic oxidative stress in Parkinson's disease
